• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number PB 10
Device Problems Gradient Increase (1270); Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583)
Patient Problems Aortic Regurgitation (1716); Stroke/CVA (1770); Non specific EKG/ECG Changes (1817); Hemorrhage/Bleeding (1888); Low Cardiac Output (2501); Vascular System (Circulation), Impaired (2572); Blood Loss (2597)
Event Date 06/12/2019
Event Type  Injury  
Manufacturer Narrative
Citation: duncan a et al.Outcomes following transcatheter aortic valve replacement for degenerative stentless versus stented bioprostheses.Jacc cardiovasc interv.2019 jul 8;12(13):1256-1263.Doi: 10.1016/j.Jcin.2019.02.036.Epub 2019 jun 12.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a comparison of the outcomes in patients with degenerated stentless or stented aortic bioprosthetic valves who underwent valve-in-valve transcatheter aortic valve replacement (tavr).All data were collected from multiple centers between 2007 and 2016.The study population included 1,598 (predominantly male; mean age 76 years), 377 of which were previously implanted with medtronic mosaic (161), hancock (138), freestyle (75), and ats 3f (3) bioprosthetic valves; 804 were implanted valve-in-valve with medtronic corevalve (528), evolut r (270), and melody (6) transcatheter valves.No serial numbers were provided.Among all corevalve and evolut r patients, 38 deaths occurred within 30 days post implant.No other details were reported.Based on the available information, medtronic product was not directly associated with the deaths.Among the entire study cohort, 74 patients died within 30 days post-tavr implant and 211 died within 1-year post-tavr implant, respectively.Based on the available information, medtronic product was not directly associated with the deaths.Among all mosaic, hancock, freestyle, and ats 3f patients, adverse events included: valve-in-valve implantation due to aortic regurgitation (mild-moderate-severe), aortic stenosis, or a combination of both, and high peak/mean aortic gradients.Based on the available information, medtronic product may have been associated with the adverse events.Among all corevalve, evolut r, and melody patients, adverse events included: new permanent pacemaker implantation, major stroke, second transcatheter valve required, coronary obstruction, mild-moderate-severe aortic regurgitation/paravalvular leak, prosthesis-patient mismatch, valve malposition (low/high implant), valve migration during index procedure (1 reported corevalve case), major bleeding, major vascular complications, decreased left ventricular ejection fraction, and elevated peak/mean aortic gradients.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MELODY TRANSCATHETER PULMONARY VALVE
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8838733
MDR Text Key152614107
Report Number2025587-2019-02385
Device Sequence Number1
Product Code NPV
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P140017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 07/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPB 10
Device Catalogue NumberPB 10
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/10/2019
Initial Date FDA Received07/29/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-